MRSA experts unveil brand new bacteria deterrent

A brand new antimicrobial agent could soon be integrated into hospitals to tackle MRSA.

 

The agent which is 1,000 times more powerful than current solutions could be introduced to items found in hospitals such as bedside tables, light switches, air conditioning, paints and plastics. 

 

The technology, Cliniweave, has been studied at Imperial College London by

Leading microbiologist Professor Mark Enright who compared its effectiveness

against three silver-based antimicrobial fabrics in reducing the bacteria associated with MRSA. 

 

The results showed that only Cliniweave-treated samples demonstrated significant antibacterial activity against high concentrations of MRSA, severely reducing bacterial numbers within just one hour. 

 

This means that Cliniweave technology in hospitals wards could eliminate bacteria at points where people interact and will beneficial in reducing the burden of infections.

 

 Professor Mark Enright said: “Our research indicates that Cliniweave is potently antibacterial; not only did it prove effective but it was also extremely fast acting.  The spread of infection continues to be a major concern in the NHS and our study suggests that Cliniweave may prove to be an important weapon in reducing the frequency of these.”